# EDGAR Filing Document

**Accession Number:** 0001371285
**File Stem:** 0001371285-23-000087
**Filing Date:** 2023-3
**Character Count:** 13543
**Document Hash:** 847a45aa66101402ec9ee8e8546823ee
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001371285-23-000087.hdr.sgml**: 20230323

**ACCESSION NUMBER**: 0001371285-23-000087

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230322

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230323

**DATE AS OF CHANGE**: 20230323

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TRUPANION, INC.
- **CENTRAL INDEX KEY:** 0001371285
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36537
- **FILM NUMBER:** 23754560

**BUSINESS ADDRESS:**
- **STREET 1:** 6100 4TH AVENUE SOUTH
- **STREET 2:** SUITE 400
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98108
- **BUSINESS PHONE:** 888-733-2685

**MAIL ADDRESS:**
- **STREET 1:** 6100 4TH AVENUE SOUTH
- **STREET 2:** SUITE 400
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98108

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TRUPANION INC.
- **DATE OF NAME CHANGE:** 20131114

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VETINSURANCE INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 20060802

?xml version="1.0" ? trup-20230322

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): March 22, 2023** 

**TRUPANION, INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-36537** | **83-0480694** |
| **(State or other jurisdiction of**<br>**incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification No.)** |

---

**6100 4th Avenue S, Suite 400** 

**Seattle, Washington 98108** 

**(Address of principal executive offices, including zip code)**

**(855) 727 - 9079** 

**(Registrant's telephone number, including area code)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| <u>Title of each class</u> | <u>Trading Symbol</u> | <u>Name of each exchange on which registered</u> |
| Common stock, $0.00001 par value per share | TRUP | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02 &nbsp;&nbsp;&nbsp;&nbsp;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** 

On March 22, 2023, Andrew Wolff, the Company's Chief Financial Officer, notified Trupanion, Inc. (the "Company") of his intent to resign effective June 1, 2023. Also on March 22, 2023, Tricia Plouf, the Company's Executive Vice President, Pricing, and Gavin Friedman, the Company's Executive Vice President, Legal, and Corporate Secretary, ceased to provide services to the Company. None of these departures was the result of any disagreement with the Company or the Board as to any accounting, financial reporting, or other legal or disclosure matter.

The Company expects to enter into a consulting agreement pursuant to which Mr. Wolff would continue to serve as a consultant to the Company to facilitate the transition to his successor.

On March 22, 2023, the Company also appointed Wei Li to serve as the Company's interim Chief Financial Officer, to be effective June 1, 2023. Mr. Li, age 42, has been with Trupanion since December 2018 in positions of increasing responsibility in the finance and accounting function, most recently as Corporate Controller. Prior to joining the Company, Mr. Li served as the financial reporting manager at Accuride Corporation from June 2016 to December 2018. Prior to Accuride, Mr. Li served in various roles in the audit and assurance function at Deloitte & Touche LLP from July 2007 to June 2014. Mr. Li holds an MBA from the University of Notre Dame, a Masters in Accounting from Shanghai University of Finance and Economics, and a Bachelor's in Business Administration from Southwestern University of Finance and Economics in China. He is a certified public accountant in both the United States and China.

**Item 9.01 &nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

---

| | | |
|:---|:---|:---|
| **(d)** | **Exhibits** | |
| | <u>Exhibit No.</u> | <u>Description</u> |
| | <u>[99.1](ex991executivetransitions.htm)</u> | Press release issued by Trupanion, Inc. dated March 23, 2023 |
| | 104 | Cover Page Interactive Data File (formatted as Inline XBRL) |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **TRUPANION, INC.** | **TRUPANION, INC.** |
| By: | /s/ Margi Tooth |
|  | Name: Margi Tooth |
|  | Title: President |

---

Date: March 23, 2023

## Exhibit 99.1

**<u>Exhibit 99.1</u>**

![trulogoenrgb2018a02.jpg](trulogoenrgb2018a02.jpg)

**Trupanion Announces Executive Leadership Transitions**

Seattle, WA -- March 23, 2023 -- <u>Trupanion</u>, Inc. (Nasdaq: TRUP) today announced the following changes to its executive leadership team:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Drew Wolff, Chief Financial Officer, will be stepping down from his position effective June 1, 2023. Thereafter, Mr. Wolff will serve as a senior advisor to the Company to support the Interim CFO, and to assist in the search and training of the incoming CFO. Trupanion has initiated an executive search for a new full-time CFO.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Wei Li, Corporate Controller, will assume the position of Interim Chief Financial Officer upon Mr. Wolff's departure. Mr. Li joined Trupanion in 2018.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Tricia Plouf, EVP of Pricing, and Gavin Friedman, EVP of Legal & Regulatory, will be departing the Company, effective immediately.

"Two years ago, we announced our 60-month strategic plan, and in that time we have made great progress growing revenue from approximately $500 million in 2020 to over $900 million in 2022," said Margi Tooth, President of Trupanion. "Growth at this rate naturally brings about change, including that of executive leadership. With our team aligned around our collective vision and mission, I am confident in our direction and what the future holds for Trupanion."

"On behalf of the entire Trupanion team and Board of Directors, I would like to thank Drew, Tricia and Gavin for their contributions to the Company," said Darryl Rawlings, Chairman and Chief Executive Officer of Trupanion. "We wish each of them success in their next chapters."

"Trupanion is making a huge difference in improving health outcomes for over a million pets. I feel honored and grateful for my time at Trupanion," said Drew Wolff, Chief Financial Officer of Trupanion. "I'm at a point in my life however, where I'd like to pursue other interests. I remain 100% committed to helping recruit my successor and facilitate a smooth transition so Trupanion can continue its incredible mission."

**About Trupanion**

Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, Europe, Puerto Rico and Australia with over 860,000 pets enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance with unlimited payouts for the life of their pets. With its patented process, Trupanion is the only North American provider with the technology to pay veterinarians directly in seconds at the time of checkout. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. Trupanion Australia is a partnership between Trupanion and Hollard Insurance Company. For more information, please visit <u>trupanion.com</u>.

------

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding its ability to continue to grow its enrollments and revenue, and otherwise execute its business plan. These forward-looking statements are based upon the current expectations and beliefs of Trupanion's management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion has no obligation to update these forward-looking statements.

In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the ability to achieve or maintain profitability and/or appropriate levels of cash flow in future periods; the ability to keep growing our membership base and revenue; the accuracy of assumptions used in determining appropriate member acquisition expenditures; the severity and frequency of claims; the ability to maintain high retention rates; the accuracy of assumptions used in pricing medical plan subscriptions and the ability to accurately estimate the impact of new products or offerings on claims frequency; actual claims expense exceeding estimates; regulatory and other constraints on the ability to institute, or the decision to otherwise delay, pricing modifications in response to changes in actual or estimated claims expense; the effectiveness and statutory or regulatory compliance of our Territory Partner model and of our Territory Partners, veterinarians and other third parties in recommending medical plan subscriptions to potential members; the ability to retain existing Territory Partners and increase the number of Territory Partners and active hospitals; compliance by us and those referring us members with laws and regulations that apply to our business, including the sale of a pet medical plan; the ability to maintain the security of our data; fluctuations in the Canadian currency exchange rate; the ability to protect our proprietary and member information; the ability to maintain our culture and team; the ability to maintain the requisite amount of risk-based capital; our ability to implement and maintain effective controls, including over financial reporting; the ability to protect and enforce Trupanion's intellectual property rights; the ability to successfully implement our alliance with Aflac; the ability to continue key contractual relationships with third parties; third-party claims including litigation and regulatory actions; the ability to recognize benefits from investments in new solutions and enhancements to Trupanion's technology platform and website; and our ability to retain key personnel.

For a detailed discussion of these and other cautionary statements, please refer to the risk factors discussed in filings with the Securities and Exchange Commission (SEC), including but not limited to, Trupanion's Annual Report on Form 10-K for the year ended December 31, 2022 and any subsequently filed reports on Forms 10-Q, 10-K and 8-K. All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval system at <u>https://www.sec.gov/</u> or the Investor Relations section of Trupanion's website at <u>https://investors.trupanion.com/.</u>

------

**Investors:**

**Investors:**

Laura Bainbridge, Vice President, Corporate Communications

<u>Investor.Relations@trupanion.com</u>